NewGenIvf (NIVF) Enterprise Value: 2022-2025
Historic Enterprise Value for NewGenIvf (NIVF) over the last 4 years, with Sep 2025 value amounting to -$3,606.1 billion.
- NewGenIvf's Enterprise Value was N/A to -$3,606.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$3,606.1 billion, marking a year-over-year change of. This contributed to the annual value of -$1.9 million for FY2024, which is 247.49% down from last year.
- Per NewGenIvf's latest filing, its Enterprise Value stood at -$3,606.1 billion for Q3 2025, which was down 172,035,351.59% from -$2.1 million recorded in Q2 2025.
- In the past 5 years, NewGenIvf's Enterprise Value registered a high of -$489,986 during Q4 2022, and its lowest value of -$3,606.1 billion during Q3 2025.
- Moreover, its 3-year median value for Enterprise Value was -$2.0 million (2024), whereas its average is -$901.5 billion.
- As far as peak fluctuations go, NewGenIvf's Enterprise Value increased by 11.06% in 2023, and later crashed by 247.49% in 2024.
- Over the past 4 years, NewGenIvf's Enterprise Value (MRQ) stood at -$489,986 in 2022, then decreased by 11.06% to -$544,155 in 2023, then crashed by 247.49% to -$1.9 million in 2024, then crashed by 190,711,223.76% to -$3,606.1 billion in 2025.
- Its Enterprise Value stands at -$3,606.1 billion for Q3 2025, versus -$2.1 million for Q2 2025 and -$1.9 million for Q4 2024.